Ignite Creation Date:
2025-12-25 @ 1:42 AM
Ignite Modification Date:
2025-12-25 @ 11:59 PM
Study NCT ID:
NCT05134194
Status:
TERMINATED
Last Update Posted:
2024-04-16
First Post:
2021-11-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Camrelizumab in Combination With Chemotherapy Regimen Comparative Chemotherapy Regimen for Metastatic Triple-negative Breast Cancer
Sponsor:
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-01-17
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-12-15
Completion Date Type:
ACTUAL
First Submit Date:
2021-11-09
First Submit QC Date:
None
Study First Post Date:
2021-11-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-14
Last Update Post Date:
2024-04-16
Last Update Post Date Type:
ACTUAL